Health care players are crossing traditional boundaries — and health care providers expect recent combinations to overturn the industry. In light of recent mergers such as CVS-Aetna and Optum-DaVita, we conducted an NEJM Catalyst Buzz Survey, sponsored by BDO, to ask the NEJM Catalyst Insights Council what impact they expect from innovative mergers and potential new entrants. By a large majority, members of the Insights Council, a qualified group of U.S. executives, clinical leaders, and clinicians involved in health care delivery, expect these mergers to disrupt the prevailing order over the next 3 years. They expect the greatest impact from the CVS-Aetna deal (if approved), followed by Amazon entering the fray. (This survey was conducted just before Amazon, JPMorgan Chase, and Berkshire Hathaway said they would form an independent health care company, which sent shock waves throughout health care and the stock market.) Google and Apple are also expected to have a significant disruptive influence, though neither company has specified its plans for the health care industry.
Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program
Article by JP Sharp, Patrick H. Conway & Rahul Rajkumar
We believe North Carolina can be a model for the nation.
Article by Nicholas Bagley, Amitabh Chandra, Craig Garthwaite & Ariel D. Stern
Three proposals for improving the law to reflect 21st-century drug development practices.
Article by Dana P. Goldman, Karen Van Nuys, Wei-Han Cheng, Jakub P. Hlávka, Luca Pani, Sylvain Chassang & Erik Snowberg
Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.
Insights Report by NEJM Catalyst & University of Utah Health
An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.
Case Study by John Grady-Benson, Michael Cremins, Elizabeth Olson, Nishwant Swami & Steven Schutzer
The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.
Case Study by Patrick Cronin, Shailesh Dominic Aranha & Alexa Boer Kimball
Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.
Insights Report by Jon Bees
NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.
Article by Steven Strongwater & Joe Kimura
Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.
Article by Jeffrey S. Berns, Aaron Glickman & Matthew S. McCoy
Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.
In a survey of the NEJM Catalyst Insights Council sponsored by Optum, respondents express enthusiasm for value-based care but have conflicting opinions about just how far along that path they should go.